Professor
Regeneron Pharmaceuticals, Inc.
South Salem, NY, United States
DB-OTO Gene Therapy in Children with Profound Hearing Loss: CHORD Trial Early Speech Results
Monday, October 19, 2026
8:54 AM - 9:00 AM PT
Disclosure information not submitted.